B7-H1 up-regulation impairs myeloid DC and correlates with disease progression in chronic HIV-1 infection

European Journal of Immunology

Volumn 38, Issue 11, 2008, Pages 3226-3236

  Wang, Xicheng ^a   Zhang, Zheng ^b   Zhang, Shuye ^b   Fu, Junliang ^b   Yao, Jinxia ^b   Jiao, Yanmei ^a   Wu, Hao ^a   Wang, Fu Sheng ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b BEIJING 302 HOSPITAL   (China)

Author keywords

B7 H1; Co stimulation; HIV; Myeloid dendritic cells; PD 1

Indexed keywords

CELL SURFACE PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; PROTEIN PROGRAMMED DEATH 1 LIGAND 1; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; CD274 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; PDCD1 PROTEIN, HUMAN;

ADAPTIVE IMMUNITY; APOPTOSIS; ARTICLE; CD4 LYMPHOCYTE COUNT; CELL MATURATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DISEASE COURSE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; UPREGULATION; VIRUS LOAD; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; BONE MARROW CELL; CHRONIC DISEASE; FEMALE; IMMUNOLOGY; MALE; MIDDLE AGED; PHYSIOLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIGENS, CD; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CD4 LYMPHOCYTE COUNT; CHRONIC DISEASE; DENDRITIC CELLS; DISEASE PROGRESSION; FEMALE; HIV-1; HUMANS; MALE; MIDDLE AGED; MYELOID CELLS;

EID: 58149339765     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200838285     Document Type: Article

References (43)

1. Banchereau, J. and Steinman, R. M., Dendritic cells and the control of immunity. Nature 1998. 392: 245-252.
2. Liu, Y. J., IPC: Professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Reu. Immunol. 2005. 23: 275-306.
3. Pachiadakis, I., Pollara, G., Chain, B. M. and Naoumov, N. V., Is hepatitis C virus infection of dendritic cells a mechanism facilitating viral persistence? Lancet Infect. Dis. 2005. 5: 296-304.
4. Donaghy, H., Pozniak, A., Gazzard, B., Qazi, N., Gilmour, J., Gotch, F. and Patterson, S., Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load. Blood 2001. 98: 2574-2576.
5. Barron, M. A., Blyveis, N., Palmer, B. E., MaWhinney, S. and Wilson, C. C., Influence of plasma viremia on defects in number and immunophenotype of blood dendritic cell subsets in human immunodeficiency virus 1-infected individuals. J. Infect. Dis. 2003. 187: 26-37.
6. Anthony, D. D., Yonkers, N. L., Post, A. B., Asaad, IL, Heinzel, E P., Lederman, M. M., Lehmann, P. V. and Valdez, H., Selective impairments in dendritic cell-associated function distinguish hepatitis C virus and HIV infection. J. Immunol. 2004. 172: 4907-4916.
7. Almeida, M., Cordero, M., Almeida, J. and Ofao, A., Persistent abnormalities in peripheral blood dendritic cells and monocytes from HIV-1-positive patients after 1 year of antiretroviral therapy. J. Acquir. Immune. Defic. Syndr. 2006. 41: 405-415.
8. Zhang, Z., Fu, J., Zhao, Q., He, Y., Jin, L., Zhang, H., Yao, J. et al., Differential restoration of myeloid and plasmacytoid dendritic cells in HIV-1-infected children after treatment with highly active antiretroviral therapy. J. Immunol. 2006. 176: 5644-5651.
9. Schmidt, B., Fujimura, S. H., Martin, J. N. and Levy, J. A., Variations in plasmacytoid dendritic cell (PDC) and myeloid dendritic cell (MDC) levels in HIV-infected subjects on and off antiretroviral therapy. J. Clin. Immunol. 2006. 26: 55-64.
10. Azzoni, L., Chehimi J., Zhou, L., Foulkes, A. S., June, R., Maino, V. C., Landay, A. et al., Early and delayed benefits of HIV-1 suppression: Timeline of recovery of innate immunity effector cells. AIDS 2007. 21: 293-305.
11. Chehimi, J., Campbell, D. E., Azzoni, L., Bacheller, D., Papasavvas, E., Jerandi, G., Mounzer, K. et al., Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in HIV-infected individuals. J. Immunol. 2002. 168: 4796-4801.
12. Smed-Sorensen, A., Lore, K., Vasudevan, J., Louder, M. K., Andersson, J., Mascola, J. R., Spetz, A. L. and Koup, R. A., Differential susceptibility to human immunodeficiency virus type 1 infection of myeloid and plasmacytoid dendritic Cells. J. Viral. 2005. 79: 8861-8869.
13. Schmitt, N., Nugeyre, M. T., Scott-Algam, D., Cumont, M. C., Barre-Sinoussi, F., Pancino, G. and Israel N., Differential susceptibility of human thymic dendritic cell subsets to X4 and R5 HIV-1 infection. AIDS 2006. 20: 533-542.
14. Cameron, P. U., Handley, A. J., Baylis, D. C., Solomon,.A. E., Bernard, N., Purcell, D. F. and Lewin, S. R., Preferential infection of DC during HIV-1 infection of blood leukocytes. J. Virol. 2007. 81: 2297-2306.
15. Groot, F., van Capel, T. M., Kapsenbeng, M. L., Berkhout, B. and de Jong, E. C., Opposing roles of blood myeloid and plasmacytoid dendritic cells in HIV-1 infection of T cells: Transmission facilitation versus replication inhibition. Blood 2006. 108: 1957-1964.
16. + T cells. J. Exp. Med. 2005. 201: 2023-2033.
17. Servet, C., Zitvogel, L. and Hosmalin, A., Dendritic cells in innate immune responses against HIV. Curr. Mol. Med. 2002. 2: 739-756.
18. Chen, L., Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat. Rev. Immunol. 2004. 4: 336-347.
19. Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpoe, A. H., Freeman, G. J. and Ahmed, R., Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006. 439: 682-687.
20. Petrovas, C., Casazza, J. P., Brenchley, J. M., Price, D. A., Gostick, E., Adams, W. C., Precopio, M. L. et al., PD-1 is a regulator of virus-specific CD8' T cell survival in HIV infection. J. Exp. Med. 2006. 203: 2281-2292.
21. Day, C. L., Kaufmann, D. E., Kiepiela, P., Brown, J. A., Moodley, E. S., Reddy, S., Mackey, E. W. et al., PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006. 443: 350-354.
22. + T cells leads to reversible immune dysfunction. Nat. Med. 2006. 12: 1198-1202.
23. Zhang, J. Y., Zhang, Z., Wang, X., Fu, J. L., Yao, J, Jiao, Y., Chen, L. et al., PD-1 up-regulation is correlated with HIV-specific memory CD8' T-cell exhaustion in typical progressors but not in long-term nonprogressors. Blood 2007. 109: 4671-4678.
24. Boni, C., Fisicaro, P., Valdatta, C., Amadei, B., Di Vincenzo, P., Giuberti, T., Laccabue, D. et al., Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J. Virol. 2007. 81: 4215-4225.
25. Urbani, S., Amadei, B., Tola, D., Massari, M., Schivazappa, S., Missale, G. and Ferrari, C., PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. J. Virol. 2006. 80: 11398-11403.
26. + T cells associated with reversible immune dysfunction. J. Virol. 2007. 81: 9249-9258.
27. Dong, H. and Chen, X., Immunoregulatory role of B7-H1 in chronicity of inflammatory responses. Cell. Mol. Immunol. 2006. 3: 179-187.
28. Curiel, T. J., Wei, S., Dong, H., Alvarez, X., Cheng, P., Mottram, P., Krzysiek, R. et al., Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat. Med. 2003. 9: 562-567.
29. Chen, L., Zhang, Z., Chen, W., Li, Y., Shi, M., Zhang, J., Wang, S. and Wang, F. S., B7-H1 up-regulation on myeloid dendritic cells significantly suppresses T cell immune function in patients with chronic hepatitis B. J. Immunol. 2007. 178: 6634-6641.
30. Trabattoni, D., Saresella, M., Biasin, M., Boasso, A., Piacentini, L., Ferrante, P., Dong, H. et al., B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression. Blood 2003. 101: 2514-2520.
31. Geng, L., Jiang, G., Fang, Y., Dong, S., Xie, H., Chen, Y., Shen, M. and Zheng, S., B7-H1 expression is upregulated in peripheral blood CD14' monocytes of patients with chronic hepatitis B virus infection, which correlates with higher serum IL-10 levels. J. Viral. Hepat. 2006. 13: 725-733.
32. Rosignoli, G., Cranage, A., Burton, C., Nelson, M., Steel, A., Gazzard, B., Gotch, F. and Imami, N., Expression of PD-L1, a marker of disease status, is not reduced by HAART in aviraemic patients. AIDS 2007. 21: 1379-1381.
33. Chen, C., Qu, Q. X, Huang, J. A., Zhu, Y. B., Ge, Y., Wang, Q. and Zhang, X. G., Expression of programmed-death receptor ligands 1 and 2 may contribute to the poor stimulatory potential of murine immature dendritic cells. Immunobiology 2007. 212: 159-165.
34. + T cell activation. Eur. J. Immunol. 2006. 36: 2472-2482.
35. Brown, J. A., Dorfman, D. M., Ma, F. R., Sullivan, E. L., Munoz, O., Wood, C. R., Greenfield, E. A. and Freeman, G. J., Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J. Immunol. 2003. 170: 1257-1266.
36. O'Garra, A. and Vieira, P., T(H)1 cells control themselves by producing interleukin-10. Nat. Reu. Immunol. 2007. 7: 425-428.
37. Deeks, S. G. and Walker, B. D., Human immunodeficiency virus controllers: Mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity 2007. 27: 406-416.
38. Blackburn, S. D. and Wherry, E. J., IL-10, T cell exhaustion and viral persistence. Trends Microbiol. 2007. 15: 143-146.
39. Brooks, D. G., Trifilo, M. J., Edelmann, K. H., Teyton, L., McGavern, D. B. and Oldstone, M. B., Interleukin-10 determines viral clearance or persistence in vivo. Nat. Med. 2006. 12: 1301-1309.
40. Ejmaes, M., Filippi, C. M., Martinic, M. M., Ling, E. M., Togher, L. M., Crotty, S. and von Herrath, M. G., Resolution of a chronic viral infection after interleukin-10 receptor blockade. J. Exp. Med. 2006. 203: 2461-2472.
41. Trabattoni, D., Schenal, M, Cesari, M., Castelletti, E., Pacei, M., Goldberg, B., Gori, A. and Clerici, M., Low interleukin-10 production is associated with diabetes in HIV-infected patients undergoing antiviral therapy. Med. Microbiol. Immunol. (Berl). 2006. 195: 125-132.
42. Muhlbauer, M., Fleck, M., Schutz, C., Weiss, T., Froh, M., Blank, C., Scholmerich, J, and Hellerbrand, C., PD-L1 is induced in hepatocytes by viral infection and by interferon-alpha and -gamma and mediates T cell apoptosig. J. Hepatol. 2006. 45: 520-528.
43. Grossman, Z., Meier-Schellersheim, M., Paul, W. E. and Picker,. L. J., Pathogenesis of HIV infection: What the virus spares is as important as what it destroys. Nat. Med. 2006. 12: 289-295.